
Azienda Unita' Sanitaria Locale Di Modena
ISNI: 0000000417562640
Azienda Unita' Sanitaria Locale Di Modena
3 Projects, page 1 of 1
assignment_turned_in Project2008 - 2011Partners:SIEMENS, OXS, UOW, PAPASAVAS, Gdańsk University of Technology +16 partnersSIEMENS,OXS,UOW,PAPASAVAS,Gdańsk University of Technology,TALANTON,CEIT,KCC,MEDMARK,UPM,Boehringer Ingelheim (Germany),OXFORD COMPUTER CONSULTANTS LIMITED,Azienda Unita' Sanitaria Locale Di Modena,ANCO,Boehringer Ingelheim (Italy),University of Ioannina,LOGICOM PUBLIC LTD,PATMOS,MEDTRONIC,LOGICOM SOLUTIONS LIMITED,University of NavarraFunder: European Commission Project Code: 215952more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2018 - 2023Partners:Azienda Unita' Sanitaria Locale Di Modena, INSERM, FERB, UM, CLINICHE GAVAZZENI SPA +15 partnersAzienda Unita' Sanitaria Locale Di Modena,INSERM,FERB,UM,CLINICHE GAVAZZENI SPA,CIMH,Aristotle University of Thessaloniki,FEDERAZIONE ALZHEIMER ITALIA,AP-HP,Charité - University Medicine Berlin,UNIGE,AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA(ASST DI MANTOVA),MCR,ASSR,University of Perugia,Southern and Eastern Norway Regional Health Authority,GAADRD,ATHENS ASSOCIATION OF ALZHEIMER'S DISEASE & RELATED DISORDERS AAADRD,CHU,Innlandet Hospital TrustFunder: European Commission Project Code: 779237Overall Budget: 2,824,040 EURFunder Contribution: 2,824,040 EURThe RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many unmet needs in this area. The major objective of the project will be to assess the effectiveness of an intervention, the special medical care unit for patients with BPSD (SCU-B), that, albeit already implemented in some European countries, is not widespread and has not been sufficiently studied so far, although it seems to be promising for its short-term efficacy (alleviating BPSD and improving quality of life of PwD) and possibly for its long term efficacy. In order to achieve this goal, RECAGE will proceed in three steps: 1) A prospective cohort study, comparing the activity of the centres endowed with a typical SCU-B with that of the other participating centres lacking this facility; the efficacy and the cost-effectiveness of the proposed intervention will be tested in the prospective study. The expected benefits are socially appreciable: improving quality of life of persons with dementia, lessening caregivers' burden, possibly delaying institutionalisation 2) A conference aiming at adapting the SCU-B model in accordance with the results of the cohort study, not only regarding its main endpoints, but also comparing the experience and the different ways of operating of the participating centres and the different socio-political context in which they act 3) A plan for scaling up the intervention in the countries who take part in the study, but where SCU-Bs are absent or sporadic as Italy and Greece.
more_vert assignment_turned_in Project2008 - 2012Partners:Universität Augsburg, DDS, UNIPR, INSALUD, ITELLIGENCE +21 partnersUniversität Augsburg,DDS,UNIPR,INSALUD,ITELLIGENCE,MEDMARK,ICCS,UPV,Azienda Unita' Sanitaria Locale Di Modena,SATE,University of Patras,MEDTRONIC,UEF,University of Stuttgart,SERGAS,WM,Charles University,SOFTWARE AG,FERRARI,ITELLIGENCE,UPM,MICRODATA,MEGA,R&S,ORT France,SWORDFunder: European Commission Project Code: 216270more_vert